UK considers prescribing e-cigarettes to help smokers quit

Sep.02.2022
UK considers prescribing e-cigarettes to help smokers quit
UK scientists recommend prescribing e-cigarettes to help millions quit smoking; results show 42% of hardcore smokers successfully quit.

Electronic cigarette research around the world, particularly in developed countries, is causing concern for those who wish to maintain the ban on electronic cigarettes rather than lift it.


The Daily Mail has reported that British scientists have concluded that electronic cigarettes should be prescribed to help millions of people quit smoking. This could potentially make England the first country in the world to license e-cigarettes as a medical product.


According to the Daily Mail, 40% of those who attempted to quit smoking using a free electronic cigarette were successful within a month.


Professor Caitlin Notley from the University of East Anglia led a pilot project involving 668 patients who were using electronic cigarettes. She stated that, "it led to a successful quit attempt within four weeks for 42% of entrenched smokers. This is particularly important as it can help those who have attempted to quit smoking multiple times but have been unsuccessful, stay away from tobacco.


Professor Notley also stated that the program was "very popular" and acknowledged that "other forms of smoking cessation support are not suitable for everyone." Her team told the nicotine and tobacco research company that they hoped electronic cigarettes would be widely used because they offer nicotine without carbon monoxide or tar.


The daily newspaper reported that this study is extremely significant and has opened up new horizons for the global tobacco market. The NHS stated that electronic cigarettes are not without risks but are better than regular cigarettes.


Previous research has found that 27.2% of people use electronic cigarettes to quit smoking, while 18.2% attempt to use patches and gum.


Last year, regulatory bodies for pharmaceuticals and health products announced that any approved electronic cigarette products would require a prescription from a doctor. "Whether it's the Covid-19 vaccine we've rolled out or the innovative public health measures we've implemented to reduce the risk of severe illnesses, this country is still a global leader in healthcare," said Health Secretary Sajid Javid.


Opening the door to e-cigarettes licensed by the NHS (UK National Health Service) could potentially lead to a significant decrease in the national smoking rate," added Javid.


GoSmokeFree.co.uk conducted a survey of 1,200 respondents to gauge their opinions on the issue. The survey revealed that 35% of participants believed that these products should be available by prescription due to their potential to aid in smoking cessation. Meanwhile, 38% were in favor of banning these products altogether and 45% felt that local anti-smoking laws were not strict enough.


Experts from around the world, particularly those from the World Vapers Alliance (WVA) and WeVape, have praised the UK for embracing science and taking strong measures to reduce tobacco harm. This is something that New Delhi should follow.


Although the World Health Organization (WHO) continues to reject electronic cigarettes and other safer alternatives to nicotine through such measures, the UK has been leading the way in reducing tobacco harms and local smoking rates through its progressive e-cigarette policies.


This is the progress of UK research, where experts are urging London authorities to influence the position of the World Health Organization (WHO). "The UK is at the forefront of reducing harm and has provided an excellent example of effective smoking cessation through e-cigarettes for other parts of the world. Our government has chosen a proven and scientifically-supported path. Before the WHO conference in November, the UK needs to strengthen its commitment to e-cigarettes and encourage other countries to do the same," said Mark Oates, Director of WeVape.


Electronic cigarettes contain nicotine and are not risk-free, but experts from the UK and US have made it clear that regulated e-cigarettes are less harmful than smoking. E-cigarettes that have obtained medicinal licenses must undergo stricter safety checks.


Smoking remains a leading cause of premature death, although smoking rates in the UK are at an all-time low. However, there are still approximately 6.1 million smokers in England.


In 2020, electronic cigarettes were the most popular aid for smokers in the UK trying to quit. They have been shown to be highly effective in supporting those trying to quit smoking, with 27.2% of smokers using e-cigarettes compared to 18.2% using nicotine replacement therapies like patches and gum.


Among individuals attempting to quit smoking, those with the highest success rates include those who used electronic cigarettes to quit smoking, as well as those who utilized local smoking cessation services. From 2020 to 2021, up to 68% of individuals were able to successfully quit smoking.


The example of the United Kingdom needs to be studied carefully in India. For a country with a population exceeding one billion, the Ministry of Health and Family Welfare should work towards minimizing the human and economic losses by reducing the risks associated with tobacco use.


Officials in India's Ministry of Health should now realize that the ban is ineffective and lifting it is necessary, which should not be considered as a means of indulgence. In fact, India must consider humane regulations that are proportional to the risks and take protective measures to prevent abuse.


However, despite the world taking the correct steps, this has not been the case in the past three years. Sadly, India has not changed or made any concessions.


Indians bear a significant burden of tobacco use, with nearly a third of the population relying on some form of it. This has resulted in almost 1.4 million deaths, close to the total population of cities like Ranchi or Jabalpur. Furthermore, the World Health Organization (WHO) has stated that the annual massive loss of $27.5 billion is due to illnesses caused by tobacco use among people aged 35 and above.


The health department has initiated numerous laws to discourage people from smoking, but the most controversial is its irrational decision towards the e-cigarette industry.


Statement


This article is compiled from third-party information and is intended for the purposes of industry exchange and learning.


This article does not represent the opinions of 2FIRSTS, and 2FIRSTS is unable to verify the truthfulness and accuracy of the article's content. The translation of this article is only intended for exchange and research within the industry.


Due to limitations in translation skills, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any statements and positions related to domestic affairs, Hong Kong, Macau, Taiwan, and foreign affairs.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please kindly contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Global Nicotine-Pouch E-Commerce Group Haypp Shuts Sweden’s Snusnetto Over Age Verification as Identity Checks Become Industry Infrastructure for New Nicotine Products
Global Nicotine-Pouch E-Commerce Group Haypp Shuts Sweden’s Snusnetto Over Age Verification as Identity Checks Become Industry Infrastructure for New Nicotine Products
Sweden's Supreme Administrative Court has declined to hear an appeal over age verification for tobacco and nicotine products collected from parcel lockers, leaving in place a lower-court ruling that geo-located BankID verification is insufficient to securely verify the actual recipient. Haypp Group has stopped tobacco and nicotine sales through Snusnetto and is deploying a new system across its other Swedish e-commerce sites to verify the age of the person who actually opens the locker and receives the shipment. The change comes as age verification across next-generation nicotine products expands from purchase checks into retail, delivery and, for some e-cigarettes, device access itself.
Regulations
Oct.20
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
A 2Firsts analysis of Virginia's liquid nicotine and vapor product certification directory identified 213 product records from 15 manufacturers. Companies associated with BAT, Altria, Imperial Brands, JTI and JUUL account for 127 entries. The directory also includes independent brands CrossBar 20K, Loon and Breeze. CrossBar advertises a 13mL disposable capable of up to 20,000 puffs, while Loon has 16 disposable entries featuring fruit, cooling and beverage-related flavors. Of all records, 120 are labeled as under FDA PMTA review. Virginia introduced revised penalties on October 1, 2026, including a minimum first-violation civil penalty of $5,000 per unlisted product, alongside new retail tobacco permitting requirements.
Regulations
Oct.30